Gabelli Funds’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-440,130
Closed -$77.9M 1103
2020
Q1
$77.9M Buy
440,130
+30,767
+8% +$5.79M 0.69% 21
2019
Q4
$78.3M Buy
409,363
+6,775
+2% +$1.22M 0.51% 40
2019
Q3
$67.8M Buy
402,588
+97,573
+32% +$15.9M 0.45% 45
2019
Q2
$51.1M Buy
305,015
+87,915
+40% +$12.2M 0.33% 76
2019
Q1
$31.8M Sell
217,100
-1,900
-0.9% -$275K 0.2% 149
2018
Q4
$29.3M Sell
219,000
-7,700
-3% -$1.26M 0.2% 145
2018
Q3
$43.2M Sell
226,700
-31,590
-12% -$5.8M 0.25% 120
2018
Q2
$43.1M Sell
258,290
-25,192
-9% -$4.04M 0.26% 107
2018
Q1
$47.7M Buy
283,482
+44,573
+19% +$7.48M 0.28% 93
2017
Q4
$39.1M Sell
238,909
-16,891
-7% -$3.03M 0.23% 124
2017
Q3
$52.4M Buy
255,800
+24,600
+11% +$5.72M 0.3% 94
2017
Q2
$56.2M Buy
231,200
+2,050
+0.9% +$482K 0.33% 79
2017
Q1
$54.7M Sell
229,150
-5,200
-2% -$1.21M 0.32% 84
2016
Q4
$49.2M Buy
234,350
+1,500
+0.6% +$311K 0.29% 92
2016
Q3
$53.6M Sell
232,850
-33,570
-13% -$8.2M 0.32% 85
2016
Q2
$61.6M Buy
266,420
+59,360
+29% +$13.7M 0.36% 69
2016
Q1
$55.5M Sell
207,060
-16,740
-7% -$4.79M 0.33% 83
2015
Q4
$69.9M Sell
223,800
-27,477
-11% -$8.18M 0.42% 58
2015
Q3
$68.3M Buy
251,277
+50,773
+25% +$15.6M 0.41% 59
2015
Q2
$60.8M Buy
200,504
+6,800
+4% +$2.03M 0.32% 90
2015
Q1
$57.6M Buy
193,704
+36,304
+23% +$10.4M 0.29% 100
2014
Q4
$40.5M Sell
157,400
-78,000
-33% -$19.5M 0.2% 155
2014
Q3
$56.8M Sell
235,400
-4,200
-2% -$940K 0.29% 104
2014
Q2
$53.4M Sell
239,600
-5,000
-2% -$1.04M 0.26% 115
2014
Q1
$50.4M Sell
244,600
-1,800
-0.7% -$357K 0.26% 113
2013
Q4
$41.4M Sell
246,400
-5,900
-2% -$922K 0.22% 138
2013
Q3
$36.3M Sell
252,300
-5,500
-2% -$733K 0.21% 146
2013
Q2
$32.5M Buy
+257,800
New +$29.2M 0.2% 159

Other funds holding AGN

Gabelli Funds's AGN Position: Q2 2020 in Review

Gabelli Funds sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 440,130 shares — an estimated $77.9M sold.

Gabelli Funds first reported a position in AGN in Q2 2013 and held it in 28 quarters. The position peaked at $78.3M in Q4 2019. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Gabelli Funds reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Gabelli Funds sold 440,130 Allergan plc shares in Q2 2020, an estimated $77.9M.
  • Gabelli Funds first reported a position in Allergan plc in Q2 2013 and held it in 28 quarters.
  • Gabelli Funds's Allergan plc position peaked at $78.3M in Q4 2019.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Gabelli Funds's 13F filing for Q2 2020, filed 13 Aug 2020.